Pulmonx Corporation
LUNG
$1.38
-$0.01-0.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.10% | -9.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.10% | -9.88% | |||
| Cost of Revenue | -7.21% | -18.11% | |||
| Gross Profit | 9.28% | -6.70% | |||
| SG&A Expenses | -10.70% | -4.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.46% | -7.16% | |||
| Operating Income | 31.20% | 2.78% | |||
| Income Before Tax | 25.96% | 7.78% | |||
| Income Tax Expenses | 45.31% | -27.68% | |||
| Earnings from Continuing Operations | 25.31% | 8.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.31% | 8.01% | |||
| EBIT | 31.20% | 2.78% | |||
| EBITDA | 31.63% | 2.47% | |||
| EPS Basic | 26.14% | 9.17% | |||
| Normalized Basic EPS | 26.76% | 8.93% | |||
| EPS Diluted | 26.14% | 9.17% | |||
| Normalized Diluted EPS | 26.76% | 8.93% | |||
| Average Basic Shares Outstanding | 1.14% | 1.25% | |||
| Average Diluted Shares Outstanding | 1.14% | 1.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||